Inhaled nitric oxide for treating pain crises in people with sickle cell disease

To capture the available body of evidence that evaluates the efficacy and safety of the use of iNO in treating pain crises in people with SCD; and to assess the treatment's relevance, robustness, and validity, in order to better guide medical practice in the fields of haematology and palliative care (since recent literature seems to favour the involvement of palliative care for those people).

This is a protocol.

Share/Save